Combined pharmacological treatment with tiagabine and clonazepam was able to rescue the impaired circadian behavior without inducing sedative effects, highlighting again the potential for Scn1a mouse models in assessing compounds against specific DS comorbidities (Han et al., 2012). Here, SCN1A is linked to Dravet syndrome.